Your browser doesn't support javascript.
loading
Function and therapeutic potential of transient receptor potential ankyrin 1 in fibrosis.
Wei, Yicheng; Cai, Jialuo; Zhu, Ruiqiu; Xu, Ke; Li, Hongchang; Li, Jianxin.
Afiliação
  • Wei Y; Third Affiliated Hospital of Shanghai University/Wenzhou People's Hospital, Wenzhou, China.
  • Cai J; Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, China.
  • Zhu R; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Xu K; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Li H; Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
  • Li J; Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, China.
Front Pharmacol ; 13: 1014041, 2022.
Article em En | MEDLINE | ID: mdl-36278189
ABSTRACT
The transient receptor potential (TRP) protein superfamily is a special group of cation channels expressed in different cell types and signaling pathways. In this review, we focus on TRPA1 (transient receptor potential ankyrin 1), an ion channel in this family that exists in the cell membrane and shows a different function from other TRP channels. TRPA1 usually has a special activation effect that can induce cation ions, especially calcium ions, to flow into activated cells. In this paper, we review the role of TRPA1 in fibroblasts. To clarify the relationship between fibroblasts and TRPA1, we have also paid special attention to the interactions between TRPA1 and inflammatory factors leading to fibroblast activation. TRPA1 has different functions in the fibrosis process in different organs, and there have also been interesting discussions of the mechanism of TRPA1 in fibroblasts. Therefore, this review aims to describe the function of TRP channels in controlling fibrosis through fibroblasts in different organ inflammatory and immune-mediated diseases. We attempt to prove that TRPA1 is a target for fibrosis. In fact, some clinical trials have already proven that TRPA1 is a potential adjuvant therapy for treating fibrosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article